Approval · Notice of Compliance 8339 · 2006

SELEPEN: Notice of Compliance 8339

Issued October 24, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8339
Date: October 24, 2006
Company: Pharmaceutical Partners Of Canada, A Division Of Abraxis Bioscience Inc.
Product type: Nonprescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Trace element

Products in this notice

Brand	DIN	Status today
SELEPEN	02139316	Cancelled Post Market

Medicinal ingredients

SELENIOUS ACID 40 MCG per ML